bpc-157 randomized controlled trial Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats BPC-157 | Reviews, Clinical Trials,

When an Injury Wont Heal: What BPC-157 and TB-500 Research Shows Some injuries respond well to rest, physical therapy, and time

This is highly speculative because: Oral bioavailability differs between species Route of administration affects systemic exposure Species differences in peptide metabolism and clearance are unknown Current Practice Patterns Current practice patterns from unregulated sources typically involve: Subcutaneous injection: 0.25-0.5 mg once or twice daily, administered near injection sites for localized effects or abdominally for systemic distribution

Laboratory animals were housed in PC cages in conventional laboratory conditions at a temperature of 20C24C, a relative humidity of 40%70% and noise level of 60 DCB

Because collagen exists throughout the body, EDS is a multisystem condition , not just a joint issue